AMD Named Company of the Year at PCR Awards 2018
Apr 16, 2018 21:15 pm UTC| Business
SANTA CLARA, Calif., April 16, 2018 -- AMD (NASDAQ:AMD) won ‘Company of the Year’ at the esteemed PCR Awards 2018 in London, UK, presented to AMD in recognition of its transformational impact across the computing...
Delek Logistics Partners, LP to Host First Quarter 2018 Conference Call on May 8
Apr 16, 2018 21:15 pm UTC| Business
BRENTWOOD, Tenn., April 16, 2018 -- Delek Logistics Partners, LP (NYSE:DKL) (“Delek Logistics”) today announced that the Partnership intends to issue a press release summarizing first quarter 2018 results after the U.S....
Delek US Holdings to Host First Quarter 2018 Conference Call on May 8
Apr 16, 2018 21:15 pm UTC| Business
BRENTWOOD, Tenn., April 16, 2018 -- Delek US Holdings, Inc. (NYSE:DK) (“Delek US”) today announced that the Company intends to issue a press release summarizing first quarter 2018 results after the U.S. stock market...
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2018 Financial Results
Apr 16, 2018 21:15 pm UTC| Business
OLDSMAR, Fla., April 16, 2018 -- Cryo-Cell International, Inc. (OTCQB:CCEL) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first...
Apr 16, 2018 21:14 pm UTC| Business
WICHITA, Kan., April 16, 2018 -- It’s been more than 65 million years since the dinosaurs roamed the wide open spaces in the center of North America, but now more than 40 life-size animatronic, moving and breathing...
The Foundation School for Autism Celebrates Current and Former Students at Homecoming
Apr 16, 2018 21:12 pm UTC| Business
SAN ANTONIO, Texas, April 16, 2018 -- Close to 100 parents and students who have walked the halls of The Foundation School for Autism gathered for the school’s first ever homecoming celebration. Current and former...
Apellis Pharmaceuticals Announces Proposed Offering of Common Stock
Apr 16, 2018 21:12 pm UTC| Business
CRESTWOOD, Ky. and WALTHAM, Mass., April 16, 2018 -- Apellis Pharmaceuticals, Inc. (Nasdaq:APLS), a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to treat disease...